|
Headache subtypes
|
|
The primary headaches
|
445 (89)
|
|
The secondary headaches
|
51 (10.2)
|
|
Painful cranial neuropathies, other facial pain and other headaches
|
4 (0.8)
|
|
Comorbid conditions
|
|
No comorbid conditions
|
484 (97.6)
|
|
Hypertension (HTN)
|
12 (2.4)
|
|
Diabetes mellitus (DM)
|
2 (.4)
|
|
Hypothyroid
|
1 (.2)
|
|
Hepatitis C virus
|
1 (0.2)
|
|
Headache that awakens the patient from sleep
|
193 (38.6)
|
|
Family history of migraine
|
20 (4)
|
|
Use caffeinated substances
|
114 (22.8)
|
|
Past history of motion sickness
|
35 (7)
|
|
Precipitants
|
|
No precipitating factors
|
11 (2.2)
|
|
Odors
|
90 (18.0)
|
|
Exercise
|
8 (1.6)
|
|
Too little sleep
|
63 (12.6)
|
|
Too much sleep
|
46(9.2)
|
|
Alcohol
|
2 (0.4)
|
|
Fatigue
|
65 (13.0)
|
|
Sunshine
|
15 (3.0)
|
|
Cold days
|
6 (1.2)
|
|
Oral contraceptive pills (OCP)
|
5 (1.0)
|
|
Loud noises
|
25 (5.0)
|
|
Anxiety or stress
|
153 (30.6)
|
|
Bright lights
|
5 (1.0)
|
|
Sexual activity
|
5 (1.0)
|
|
Abortive treatment
|
|
Not using any drugs
|
76 (15.2)
|
|
Simple analgesia including paracetamol and NSAID
|
224 (44.8)
|
|
Using more than one type of simple analgesia
|
179 (35.8)
|
|
Selective 5-hydroxytryptamine (5HT) receptor agonists (Triptans)
|
16 (3.2)
|
|
Vasoconstrictors like ergot preparations
|
5 (1.0)
|
|
Preventive treatment
|
()
|
|
Not using any drugs
|
98 (19.6)
|
|
Simple analgesia including paracetamol and NSAID
|
79 (15.8)
|
|
Using more than one type of simple analgesia
|
74 (14.8)
|
|
Selective 5-hydroxytryptamine (5HT) receptor agonists (Triptans)
|
2 (0.4)
|
|
Vasoconstrictors like ergot preparations
|
5 (1.0)
|
|
Antidepressants including amitriptyline and SSRI’s
|
85 (17.0)
|
|
Antiepileptic agents
|
|
Topiramate
|
51 (10.2)
|
|
Valproate
|
21 (4.2)
|
|
Carbamazepine
|
14 (2.8)
|
|
Antihypertensive
|
|
Propranolol
|
31 (6.2)
|
|
Angiotensin-converting enzyme (ACE) inhibitors
|
8 (1.6)
|
|
Natural remedies (like Feverfew)
|
16 (3.2)
|
|
Multivitamin preparations
|
5 (1.0)
|
|
Chlorphenamine (nasal decongestant)
|
11 (2.2)
|
